Financhill
Back

Enanta Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

ENTA
Enanta Pharmaceuticals, Inc.

Last Price:
$14.24
Seasonality Move:
-9.41%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Enanta Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.12 Buy
20-day SMA: 13.82 Buy
50-day SMA: 13.99 Buy
200-day SMA: 10.36 Buy
8-day EMA: 14.2 Buy
20-day EMA: 13.92 Buy
50-day EMA: 13.64 Buy
200-day EMA: 11.39 Buy

Enanta Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 56.03 Buy
Chaikin Money Flow: 104719 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.05 - 14.21) Buy
Bollinger Bands (100): (11.5 - 14.66) Buy

Enanta Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Enanta Pharmaceuticals, Inc. Stock

Is Enanta Pharmaceuticals, Inc. Stock a Buy?

ENTA Technical Analysis vs Fundamental Analysis

Buy
51
Enanta Pharmaceuticals, Inc. (ENTA) is a Buy

Is Enanta Pharmaceuticals, Inc. a Buy or a Sell?

Enanta Pharmaceuticals, Inc. Stock Info

Market Cap:
415M
Price in USD:
14.30
Share Volume:
115.3K

Enanta Pharmaceuticals, Inc. 52-Week Range

52-Week High:
17.15
52-Week Low:
4.09
Buy
51
Enanta Pharmaceuticals, Inc. (ENTA) is a Buy

Enanta Pharmaceuticals, Inc. Share Price Forecast

Is Enanta Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Enanta Pharmaceuticals, Inc.

Is Enanta Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.42 per share, and a decrease next year of $0.29 per share.

Technical Analysis of Enanta Pharmaceuticals, Inc.

Should I short Enanta Pharmaceuticals, Inc. stock?

* Enanta Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.